Press releases
- Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
- Azenta to Participate in the Jefferies Global Healthcare Conference
- Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
- Azenta Announces CEO Succession Plan
- Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
- Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
- Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
- Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
More ▼
Key statistics
As of last trade, Azenta Inc (BA3:FRA) traded at 50.00, 28.21% above the 52 week low of 39.00 set on Jul 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 50.00 |
---|---|
High | 50.00 |
Low | 50.00 |
Bid | 49.20 |
Offer | 51.00 |
Previous close | 48.80 |
Average volume | 97.86 |
---|---|
Shares outstanding | 53.92m |
Free float | 52.86m |
P/E (TTM) | -- |
Market cap | 2.84bn USD |
EPS (TTM) | -2.74 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:38 BST.
More ▼